Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluSHED-2 viral shedding after live attenuated influenza vaccine in children
2018-002470-42Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by Imperial College London. Primary endpoint: Type-specific vaccine virus shedding over 8 days after vaccination. Started Jul 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2018-002470-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002470-42.